NBSE

NeuBase Therapeutics, Inc. Common Stock
NBSE

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

NBSE was delisted on the 10th of May, 2024.

Back to rankings

3 hedge funds and large institutions have $4.95K invested in NeuBase Therapeutics, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $

less funds holding in top 10

Funds holding in top 10: →

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
3
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$4.95K

Top Sellers

1
-$61.3K
2
-$40K
3
-$28.1K
4
CMU
Carnegie Mellon University
Pennsylvania
-$21.1K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$8.54K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$4.95K
2
–
3
–
4
–
5
–
6
–
7
–
8
–
9
–
10
–
11
–
12
–
13
–
14
–
15
–
16
–
17
–